[go: up one dir, main page]

DE4313428A1 - Combination patent comprising alpha -lipoic acid + pantothenic acid (or dexpanthenol) against inflammations, skin diseases of inflammatory + allergic nature, poorly healing wounds - Google Patents

Combination patent comprising alpha -lipoic acid + pantothenic acid (or dexpanthenol) against inflammations, skin diseases of inflammatory + allergic nature, poorly healing wounds

Info

Publication number
DE4313428A1
DE4313428A1 DE19934313428 DE4313428A DE4313428A1 DE 4313428 A1 DE4313428 A1 DE 4313428A1 DE 19934313428 DE19934313428 DE 19934313428 DE 4313428 A DE4313428 A DE 4313428A DE 4313428 A1 DE4313428 A1 DE 4313428A1
Authority
DE
Germany
Prior art keywords
dexpanthenol
skin diseases
alpha
acid
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19934313428
Other languages
German (de)
Inventor
Margarethe Rabien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19924201196 priority Critical patent/DE4201196C2/en
Priority claimed from DE19924201196 external-priority patent/DE4201196C2/en
Application filed by Individual filed Critical Individual
Priority to DE19934313428 priority patent/DE4313428A1/en
Publication of DE4313428A1 publication Critical patent/DE4313428A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Medicaments which contain at least alpha -lipoic acid + pantothenic acid (or dexpanthenol) against skin diseases, disorders of the hair-forming organs, functional disturbances of the gastrointestinal tract, burns and extraction wounds, ulcers and fissures and other poorly healing wounds.

Description

Kombinationspatent in dem α-Liponsäure + Pantothensäure (bzw. Dexpanthenol) gegen Mundschleimhauterkrankungen, entzündliche und allergische Erkrankungen der Atemwege, Funktionsstörungen des Magen-Darm-Kanals und der Leber.Combination patent in the α-lipoic acid + pantothenic acid (or dexpanthenol) against oral mucosal diseases, inflammatory and allergic Respiratory disorders, gastrointestinal dysfunction and the liver.

Hautkrankheiten entzündlicher und allergischer Natur (Ekzeme, Juckreiz, Sonnenbrand).Inflammatory and allergic skin diseases (eczema, itching, Sunburn).

Erkrankungen der haarbildenden Organe wie fleckförmiger oder totaler Haarausfall, Trockenheit, Brüchigkeit und Entfärbung der Haare, Schuppenbildung.Diseases of the hair-forming organs such as blotchy or total Hair loss, dryness, brittleness and discoloration of the hair, Dandruff formation.

Die Heilung von Brand-, Extraktionswunden, Schürf- und infizierten Wunden wird ebenso gefördert wie die von Geschwüren und Fissuren.The healing of burns, extraction wounds, abrasions and infected Wounds are promoted as well as ulcers and fissures.

Ataxiemedikament α-Liponsäure + Panthothensäure (bzw. Dexpanthenol) ist bereits bekannt.Ataxia drug α-lipoic acid + pantothenic acid (or dexpanthenol) is already known.

Claims (1)

Arzneimittel, die mindestens α-Liponsäure + Panthothensäure (bzw. Dexpanthenol) enthalten gegen Hautkrankheiten, Störungen der haarbildenden Organe, Funktionsstörungen des Magen-Darm-Kanals, Brand- und Extraktionswunden, Geschwüre und Fissuren und andere schlecht heilende Wunden.Medicines containing at least α-lipoic acid + pantothenic acid (or dexpanthenol) contain against skin diseases, Disorders of the hair-forming organs, functional disorders of the Gastrointestinal tract, burns and extraction wounds, ulcers and fissures and other poorly healing wounds.
DE19934313428 1992-01-18 1993-04-26 Combination patent comprising alpha -lipoic acid + pantothenic acid (or dexpanthenol) against inflammations, skin diseases of inflammatory + allergic nature, poorly healing wounds Withdrawn DE4313428A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19924201196 DE4201196C2 (en) 1992-01-18 1992-01-18 Medicines used to treat polyneuropathy
DE19934313428 DE4313428A1 (en) 1992-01-18 1993-04-26 Combination patent comprising alpha -lipoic acid + pantothenic acid (or dexpanthenol) against inflammations, skin diseases of inflammatory + allergic nature, poorly healing wounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19924201196 DE4201196C2 (en) 1992-01-18 1992-01-18 Medicines used to treat polyneuropathy
DE19934313428 DE4313428A1 (en) 1992-01-18 1993-04-26 Combination patent comprising alpha -lipoic acid + pantothenic acid (or dexpanthenol) against inflammations, skin diseases of inflammatory + allergic nature, poorly healing wounds

Publications (1)

Publication Number Publication Date
DE4313428A1 true DE4313428A1 (en) 1994-10-27

Family

ID=25911054

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19934313428 Withdrawn DE4313428A1 (en) 1992-01-18 1993-04-26 Combination patent comprising alpha -lipoic acid + pantothenic acid (or dexpanthenol) against inflammations, skin diseases of inflammatory + allergic nature, poorly healing wounds

Country Status (1)

Country Link
DE (1) DE4313428A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1039891A4 (en) * 1997-11-17 2003-06-11 Nicholas V Dr Perricone Treatment of scar tissue using lipoic acid
CN107789660A (en) * 2016-08-31 2018-03-13 杜建 It is a kind of to be used for skin and the medical dressing of soft tissue injury

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1039891A4 (en) * 1997-11-17 2003-06-11 Nicholas V Dr Perricone Treatment of scar tissue using lipoic acid
CN107789660A (en) * 2016-08-31 2018-03-13 杜建 It is a kind of to be used for skin and the medical dressing of soft tissue injury

Similar Documents

Publication Publication Date Title
EP0382066A3 (en) Use of dihydroliponic acid as an analgetic, antiphlogistic and/or cytoprotective agent
DE69334008D1 (en) Terfenadine carboxylate and the treatment of allergic diseases
ATE158182T1 (en) MEDICINAL PRODUCTS AND THEIR PRODUCTION AND USE IN THE COMBAT OF PAIN AND/OR INFLAMMATION IN ANIMALS AND HUMAN BEINGS
DE69526882T2 (en) Preparations containing esculoside and their use in cosmetics and pharmacy
BR9406979A (en) Compound, pharmaceutical composition for treating an inflammatory disease susceptible to treatment with a non-steroidal anti-inflammatory agent processes for treating an inflammatory disease and for preparing a pharmaceutically acceptable salt compound use of a non-steroidal anti-inflammatory pharmaceutical composition compound
RU93047799A (en) COMPOSITIONS CONTAINING RETAIC ACIDS AND TOKOFEROL
DE69841367D1 (en) PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD FOR THE PRODUCTION THEREOF, THE USE OF SUCH DERIVATIVES AND MEDICAMENTS
CA2124677A1 (en) Immunopotentiatory agents and physiologically acceptable salts thereof
DE69221640D1 (en) TOPICAL AGENT AGAINST FREE RADICALS WHICH CONTAINS SUPEROXYD DISMUTASE AND A PHOSPHONIC ACID DERIVATIVE
RU92016463A (en) APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS
KR960000855A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
DK284386A (en) PHARMACEUTICAL PREPARATION FOR SKIN DISORDERS
KR960010002A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
CA2035951A1 (en) Bilobalide derivatives, their applications and formulations containing them
IT1255968B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXICOLIC ACID
DE4313428A1 (en) Combination patent comprising alpha -lipoic acid + pantothenic acid (or dexpanthenol) against inflammations, skin diseases of inflammatory + allergic nature, poorly healing wounds
DE69005160T2 (en) Use of 5'-deoxy-5'-methylthioadenosine, s-adenylmethionine and their salts for the production of pharmaceutical preparations for promoting hair growth in patients with baldness.
KR960010003A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
RU93019879A (en) POWDLE
DE1922192C2 (en) Compositions for the treatment of trophic disorders of the skin and processes for their preparation
EP0009793A3 (en) Pharmaceutical composition containing a derivative of 2-(retinylidene)-malonic acid, manufacturing process and application
JPH05246822A (en) Antibacterial agent
DE2651947A1 (en) Compsns. contg. glucaric acid or its derivs. - useful as antibacterial and antifungal medicaments, food preservatives, microbicides and disinfectants
KR940011006A (en) Periodontal disease prevention and therapeutic composition comprising golden extract as an active ingredient
DE59001796D1 (en) USE OF A HYDROXYOCTADECADIENIC ACID WHOSE ACID OXIDIZED TO THE KETOFORM, AND THEIR DERIVATIVES FOR THE THERAPY OF OESTROGEN-DEPENDENT DISEASES, AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Legal Events

Date Code Title Description
AF Is addition to no.

Ref country code: DE

Ref document number: 4201196

Format of ref document f/p: P

AF Is addition to no.

Ref country code: DE

Ref document number: 4201196

Format of ref document f/p: P

8141 Disposal/no request for examination